Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AB KIROPRAKTISK KLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   2.7% 1.7% 1.5% 1.5% 1.8% 2.6% 18.2% 17.9%   Credit score (0-100)   62 74 76 74 70 60 8 8   Credit rating   BBB A A A A BBB B B   Credit limit (kDKK)   0.0 0.8 3.2 2.7 0.3 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   726 827 702 854 654 511 0.0 0.0   EBITDA   -33.0 137 140 79.6 -2.9 -5.9 0.0 0.0   EBIT   -33.0 137 140 79.6 -2.9 -5.9 0.0 0.0   Pre-tax profit (PTP)   -36.1 129.9 172.5 70.1 -42.0 39.2 0.0 0.0   Net earnings   -29.8 101.5 133.9 54.5 -26.4 39.9 0.0 0.0   Pre-tax profit without non-rec. items   -36.1 130 173 70.1 -42.0 39.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 81.7 81.7 81.7 0.0 0.0 0.0   Shareholders equity total   602 596 619 561 420 400 214 214   Interest-bearing liabilities   18.1 64.2 163 186 250 254 0.0 0.0   Balance sheet total (assets)   762 795 973 856 719 689 214 214   Net Debt   -37.3 -22.6 -607 -588 -377 -386 -214 -214     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   726 827 702 854 654 511 0.0 0.0   Gross profit growth   -15.5% 13.8% -15.0% 21.6% -23.4% -21.9% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% -8.0% 18.5% -6.4% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   762 795 973 856 719 689 214 214   Balance sheet change%   -14.2% 4.3% 22.4% -12.0% -16.0% -4.1% -69.0% 0.0%   Added value   -33.0 136.6 140.1 79.6 -2.9 -5.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 82 0 0 -82 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -4.5% 16.5% 19.9% 9.3% -0.4% -1.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -4.0% 17.5% 20.2% 9.0% -0.1% 7.4% 0.0% 0.0%   ROI %   -4.8% 21.3% 24.6% 10.6% -0.1% 7.9% 0.0% 0.0%   ROE %   -4.5% 16.9% 22.0% 9.2% -5.4% 9.7% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   79.0% 75.0% 63.6% 65.5% 58.4% 58.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   113.2% -16.6% -433.4% -739.4% 12,830.3% 6,593.1% 0.0% 0.0%   Gearing %   3.0% 10.8% 26.3% 33.1% 59.5% 63.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   31.1% 16.2% 5.2% 6.8% 19.1% 5.1% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   0.4 0.6 2.8 2.8 2.1 2.4 0.0 0.0   Current Ratio   0.4 0.6 2.8 2.8 2.1 2.4 0.0 0.0   Cash and cash equivalent   55.4 86.9 770.1 774.0 627.3 640.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -96.6 -78.0 -7.5 -84.4 -216.0 -211.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -33 137 140 86 -3 -6 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -33 137 140 86 -3 -6 0 0   EBIT / employee   -33 137 140 86 -3 -6 0 0   Net earnings / employee   -30 102 134 59 -24 39 0 0